Boyko, A N <br/><br/>
[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study].  [electronic resource] 

 -  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova   
 - 61-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1997-7298 
<br/><br/><label>Standard No.: </label>10.17116/jnevro201611610261-67  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Double-Blind Method<br/>Glatiramer Acetate--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Magnetic Resonance Imaging<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Peptides<br/>Recurrence<br/>Therapeutic Equivalency